All Stories

  1. Future Direction of Nanotherapy in the Management of Hepatocellular Carcinoma
  2. Aptamers and Their Potential in Site-Specific Nanotherapy Against Hepatocellular Carcinoma
  3. Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy
  4. Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
  5. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice
  6. Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain
  7. Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer
  8. Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology
  9. Is Type 2 Diabetes Mellitus a Predisposal Cause for Developing Hepatocellular Carcinoma?
  10. Size Dependent Variations of Phospholipid Based Vesicular Drug Carriers in Systemic Drug Activity
  11. Editorial (Thematic Issue: “Nanosize Drug Delivery System”)
  12. Peptides, Proteins and Peptide/Protein-Polymer Conjugates as Drug Delivery System
  13. Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles
  14. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy
  15. Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study
  16. Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats
  17. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation
  18. Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers